CN112807366A - Traditional Chinese medicine composition for promoting blood circulation and diminishing swelling - Google Patents

Traditional Chinese medicine composition for promoting blood circulation and diminishing swelling Download PDF

Info

Publication number
CN112807366A
CN112807366A CN202110138997.7A CN202110138997A CN112807366A CN 112807366 A CN112807366 A CN 112807366A CN 202110138997 A CN202110138997 A CN 202110138997A CN 112807366 A CN112807366 A CN 112807366A
Authority
CN
China
Prior art keywords
parts
swelling
traditional chinese
chinese medicine
blood circulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110138997.7A
Other languages
Chinese (zh)
Inventor
谢灼明
谢幸芫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110138997.7A priority Critical patent/CN112807366A/en
Publication of CN112807366A publication Critical patent/CN112807366A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236—Ligusticum (licorice-root)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254—Acanthopanax or Eleutherococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/89—Cyperaceae (Sedge family)
    • A61K36/8905—Cyperus (flatsedge)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for promoting blood circulation and relieving swelling, and belongs to the technical field of traditional Chinese medicines. The Chinese medicinal composition is prepared by matching pure natural Chinese medicaments, and the medicaments are compatible and gain mutually, so that the Chinese medicinal composition has excellent effects of promoting qi circulation, relieving swelling, removing blood stasis and activating blood; the product has wide application range, high curative rate, high safety and no toxic side effect. The invention also discloses a preparation method of the traditional Chinese medicine composition for promoting blood circulation and relieving swelling, which has simple operation steps, does not need heating or extraction and other steps, and can realize industrialized large-scale production and daily quick preparation and use. The invention also discloses a medicine for promoting blood circulation and diminishing swelling, which comprises the traditional Chinese medicine composition.

Description

Traditional Chinese medicine composition for promoting blood circulation and diminishing swelling
Technical Field
The invention relates to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for promoting blood circulation and relieving swelling.
Background
With the improvement of living standard of people, more and more people begin to pay attention to the physical health of people and begin some sports after work. However, due to poor self-foundation, unscientific exercise force or lack of attention to protection during exercise, unexpected situations such as sprain, soft tissue injury, joint swelling and even fracture often occur easily, so that not only can the physical activity be continued, but also the normal life can be affected, and people who are seriously ill and are not healed after long-term injury can possibly suffer from physical disability.
Most of the common methods for the above situations are oral western medicines for relieving pain and diminishing inflammation, and are assisted with physical therapies such as ice compress and massage, however, the methods basically only have the effects of relieving pain of patients and inhibiting disease deterioration, the content of effective components of the medicines is low, and the deep injuries are difficult to be radically cured; the existing Chinese patent medicines basically have the defects of single application range, low cure rate, large side effect and the like.
Disclosure of Invention
Based on the defects of the prior art, the invention aims to provide the traditional Chinese medicine composition which has wide application range, no obvious toxic or side effect, synergistic effect of effective components and high treatment efficiency and can be used for promoting blood circulation and diminishing swelling.
In order to achieve the purpose, the invention adopts the technical scheme that:
a traditional Chinese medicine composition for promoting blood circulation and reducing swelling comprises the following components in parts by weight: 40-60 parts of cape jasmine, 10-30 parts of rhizoma cyperi, 20-40 parts of raw rhubarb, 10-30 parts of artemisia anomala, 5-20 parts of madder root, 30-50 parts of radix euphorbiae ceolatae, 4-15 parts of salvia miltiorrhiza, 2-20 parts of radix angelicae pubescentis, 10-30 parts of radix rehmanniae and 2-15 parts of ligusticum chuanxiong hort.
In the components of the traditional Chinese medicine composition for promoting blood circulation and relieving swelling, the twig is bitter and cold, and has the effects of clearing heat and promoting diuresis, cooling blood and detoxifying, and relieving swelling and pain; the rhizoma cyperi is pungent, slightly bitter and mild, and can be used for regulating qi, relieving pain, promoting qi circulation, activating blood circulation and relieving pain and swelling; the raw rhubarb is bitter and cold in nature and has the functions of purging and eliminating accumulation, cooling blood and detoxifying, removing blood stasis and dredging channels, reducing swelling and relieving pain and the like; herba Artemisiae Anomalae is bitter and warm in nature, and is commonly used in medicines for promoting blood circulation, dredging channels, removing blood stasis, relieving pain and treating traumatic injury; radix Rubiae is bitter and cold in nature, and has effects in relieving swelling, dispelling blood stasis, relieving pain, and activating collateral flow; radix Euphorbiae antiquorum is pungent in flavor, slightly bitter in taste, slightly fragrant in flavor, and suitable for clearing heat, removing toxic substances, dispelling pathogenic wind, promoting diuresis, promoting blood circulation, relaxing muscles and tendons, removing blood stasis, and relieving swelling; salvia miltiorrhiza is bitter in taste and slightly cold in nature, and can be used for activating blood circulation, removing blood stasis, stimulating the menstrual flow and relieving pain; the radix angelicae pubescentis is pungent and bitter in property and slightly warm in property, and can expel wind and remove dampness, relieve arthralgia and pain and treat wind-cold-dampness when being used as a medicine, and is specially used for treating various arthralgia, waist and knee pain; the rehmannia root is sweet and cold, and has the effects of clearing heat and cooling blood, nourishing yin and promoting the production of body fluid and treating injuries caused by iron attack; chuan Xiong is pungent and warm in nature, and can activate blood and move qi, dispel wind and alleviate pain, and move qi and remove blood stasis and detumescence after being used as medicine.
The above components are matched with each other, so that the medicine can be suitable for symptoms such as soft tissue injury, contusion, muscle strain and swelling and pain caused by fracture caused by various external forces or internal dislocation.
In addition, the traditional Chinese medicine raw materials of the components can be replaced by products obtained by processing or refining the raw materials, such as traditional Chinese medicine extracts or traditional Chinese medicine concentrated solutions, and the traditional Chinese medicine composition obtained by combining and matching the products can still achieve the same effect.
The traditional Chinese medicine composition for promoting blood circulation and removing swelling is prepared by matching pure natural traditional Chinese medicines, and the medicines are coordinated and matched, so that the traditional Chinese medicine composition is mutually beneficial and has excellent effects of promoting qi circulation and removing swelling, and removing blood stasis and promoting blood circulation; the product has wide application range, high curative rate, high safety and no toxic side effect.
Preferably, the traditional Chinese medicine composition for promoting blood circulation and diminishing swelling comprises the following components in parts by weight: 50-60 parts of cape jasmine, 12-25 parts of rhizoma cyperi, 25-40 parts of raw rhubarb, 10-25 parts of artemisia anomala, 8-18 parts of madder root, 35-50 parts of radix euphorbiae ceolatae, 4-15 parts of salvia miltiorrhiza, 2-14 parts of radix angelicae pubescentis, 12-25 parts of radix rehmanniae and 2-10 parts of ligusticum chuanxiong hort.
The traditional Chinese medicine composition prepared by the formula has excellent effects of promoting blood circulation to remove blood stasis and setting bones to reduce swelling.
The invention also aims to provide a preparation method of the traditional Chinese medicine composition for promoting blood circulation and diminishing swelling, which comprises the following steps: the traditional Chinese medicine composition for promoting blood circulation and relieving swelling is prepared by mixing the components of the traditional Chinese medicine composition for promoting blood circulation and relieving swelling in proportion, drying, crushing and sieving.
The preparation method of the traditional Chinese medicine composition has simple operation steps, does not need heating or extraction and other steps, and can realize industrialized large-scale production and daily quick preparation and use.
Preferably, the mesh number of the sieve is 80-120 meshes.
The traditional Chinese medicine composition obtained by sieving with the size is smaller in particle size and is easier to be used as a medicine and used.
The invention also aims to provide a medicine for promoting blood circulation and diminishing swelling, which comprises the traditional Chinese medicine composition.
The traditional Chinese medicine composition is prepared from pure traditional Chinese medicines, each traditional Chinese medicine has high harmony and mutual synergism, when the traditional Chinese medicine composition is used for preparing medicines, the obtained medicines have no toxic or side effect, have obvious effects of treating symptoms such as extravasated blood swelling pain and the like, and have quicker effect and higher cure rate compared with the existing medicines.
Preferably, the dosage forms of the blood circulation promoting and swelling diminishing medicine comprise ointments, patches and pastes.
The traditional Chinese medicine composition has strong applicability, and can be added into medicines with various dosage forms for promoting blood circulation and diminishing swelling.
Preferably, the blood circulation promoting and swelling diminishing medicine comprises a blood circulation promoting and swelling diminishing external application ointment;
more preferably, the preparation method of the externally-applied ointment comprises the following steps: adding hot boiled water or honey into the traditional Chinese medicine composition, mixing and blending into ointment, and obtaining the externally applied ointment for activating blood circulation and reducing swelling.
The traditional Chinese medicine composition has stable property and no irritation, and can obtain the medicinal ointment special for external application treatment only by being supplemented with a mild carrier.
More preferably, the external application ointment only needs to be pasted on the affected part for bandaging after being applied to gauze or thin film paper with a corresponding area according to the area of the affected part, and the ointment is mild and non-irritant to the skin, and can realize the treatment of the affected part without using additional treatment medicaments or auxiliary equipment.
The invention has the beneficial effects that: the invention provides a traditional Chinese medicine composition for promoting blood circulation and removing swelling, which is prepared by matching pure natural traditional Chinese medicines, and the medicines are coordinated and matched, so that the traditional Chinese medicine composition is mutually beneficial and has excellent effects of promoting qi circulation and removing swelling, and removing blood stasis and promoting blood circulation; the product has wide application range, high curative rate, high safety and no toxic side effect. The invention also provides a preparation method of the traditional Chinese medicine composition for promoting blood circulation and relieving swelling, which has simple operation steps, does not need heating or extraction and other steps, and can realize industrialized large-scale production and daily quick preparation and use. The invention also provides a medicine for promoting blood circulation and diminishing swelling, which comprises the traditional Chinese medicine composition.
Detailed Description
For better illustrating the objects, technical solutions and advantages of the present invention, the present invention will be further described with reference to specific examples, which are intended to be understood in detail, but not intended to limit the present invention. In the examples of the present invention and the comparative examples, 1g of the component weight corresponds to 1 part by weight described in the summary of the invention of the specification.
Example 1
The invention relates to an embodiment of a traditional Chinese medicine composition for promoting blood circulation and diminishing swelling.
The traditional Chinese medicine composition for promoting blood circulation and reducing swelling comprises the following components in parts by weight: 50g of lespedeza, 20g of rhizoma cyperi, 30g of raw rhubarb, 20g of artemisia anomala, 15g of madder, 40g of radix euphorbiae ceaefolii, 8g of salvia miltiorrhiza, 6g of radix angelicae pubescentis, 25g of radix rehmanniae and 6g of ligusticum chuanxiong hort.
The preparation method of the traditional Chinese medicine composition comprises the following steps: mixing the components, drying, crushing and sieving by a 100-mesh sieve to obtain the traditional Chinese medicine composition.
Example 2
The invention relates to an embodiment of a traditional Chinese medicine composition for promoting blood circulation and diminishing swelling.
The traditional Chinese medicine composition for promoting blood circulation and reducing swelling comprises the following components in parts by weight: 55g of cape jasmine fruit, 25g of rhizoma cyperi, 40g of raw rhubarb, 10g of artemisia anomala, 8g of madder root, 45g of radix euphorbiae ceaefolii, 15g of salvia miltiorrhiza, 10g of radix angelicae pubescentis, 12g of radix rehmanniae and 10g of ligusticum chuanxiong hort.
The preparation method of the traditional Chinese medicine composition comprises the following steps: mixing the components, drying, crushing and sieving by a 100-mesh sieve to obtain the traditional Chinese medicine composition.
Example 3
The invention relates to an embodiment of a traditional Chinese medicine composition for promoting blood circulation and diminishing swelling.
The traditional Chinese medicine composition for promoting blood circulation and reducing swelling comprises the following components in parts by weight: 60g of cape jasmine fruit, 12g of nutgrass galingale rhizome, 25g of raw rhubarb, 25g of diverse wormwood herb, 18g of madder root, 35g of radix euphorbiae ceaefolii, 4g of salvia miltiorrhiza, 2g of radix angelicae pubescentis, 25g of rehmannia root and 5g of ligusticum chuanxiong hort.
The preparation method of the traditional Chinese medicine composition comprises the following steps: mixing the components, drying, crushing and sieving by a 100-mesh sieve to obtain the traditional Chinese medicine composition.
Comparative example 1
The invention relates to a comparative example of a traditional Chinese medicine composition for promoting blood circulation and diminishing swelling.
The traditional Chinese medicine composition for promoting blood circulation and diminishing swelling comprises the following components in parts by weight: 20g of rhizoma cyperi, 30g of raw rhubarb, 20g of artemisia anomala, 15g of madder root, 8g of salvia miltiorrhiza, 6g of radix angelicae pubescentis, 25g of radix rehmanniae and 6g of ligusticum chuanxiong hort.
The preparation method of the traditional Chinese medicine composition in the comparative example is the same as that of example 1.
Comparative example 2
The invention relates to a comparative example of a traditional Chinese medicine composition for promoting blood circulation and diminishing swelling.
The traditional Chinese medicine composition for promoting blood circulation and diminishing swelling comprises the following components in parts by weight: 50g of cape jasmine fruit, 20g of nutgrass galingale rhizome, 20g of diverse wormwood herb, 15g of madder root, 40g of Euphorbia antiquorum root, 8g of salvia miltiorrhiza, 6g of pubescent angelica root, 25g of rehmannia root and 6g of Szechwan lovage rhizome.
The preparation method of the traditional Chinese medicine composition in the comparative example is the same as that of example 1.
Comparative example 3
The invention relates to a comparative example of a traditional Chinese medicine composition for promoting blood circulation and diminishing swelling.
The traditional Chinese medicine composition for promoting blood circulation and diminishing swelling comprises the following components in parts by weight: 10g of lespedeza, 50g of rhizoma cyperi, 30g of raw rhubarb, 20g of artemisia anomala, 15g of madder, 10g of radix euphorbiae ceaefolii, 8g of salvia miltiorrhiza, 6g of radix angelicae pubescentis, 25g of radix rehmanniae and 20g of ligusticum chuanxiong hort.
The preparation method of the traditional Chinese medicine composition in the comparative example is the same as that of example 1.
Effect example 1
In order to verify the use effect of the traditional Chinese medicine composition for promoting blood circulation and reducing swelling, the inventor adds hot boiled water or honey according to the actual condition to mix the traditional Chinese medicine composition obtained in the embodiment 1 to form an ointment-shaped external application ointment, clinically applies the external application ointment to a patient diagnosed with soft tissue injury (patients with bleeding from epidermal wound and drug allergy are excluded; if the patient is diagnosed with bone fracture displacement or bone loss, the affected part of the patient is reset or fixed outside the bone fracture and then externally applied), when the external application ointment is used, the external application ointment is applied to the affected part after being coated with gauze or film paper with a corresponding area according to the actual area of the affected part, the dressing is carried out every other day until the second re-diagnosis after the treatment course, statistics is carried out on cases with curative effect, and the drug effect, effectiveness and improvement are evaluated by comparing the initial condition and the actual cure degree.
405 cases of clinical soft tissue injury. According to statistics, 161 cases of affected parts as crus ankles are counted, wherein 97 cases of significant effect, 48 cases of effective effect and 16 cases of improvement are counted; 121 cases with the affected part being the palm part of the wrist are treated, and in the case, 72 cases are significant, 36 cases are significant and 13 cases are improved; the cases with knee at the affected part were 61, and 37 significant cases, 18 significant cases and 6 better cases were mentioned in this example; 33 cases with the affected parts at the shoulders and elbows are shown, 20 cases with obvious effect, 10 cases with effective effect and 3 cases with improvement in the cases; 16 cases of affected parts at the chest rib and waist are shown as 6 cases, 9 cases and 1 column of improvement cases; 13 cases with head as affected part were treated, 4 cases were significantly effective, 5 cases were effective, and 4 cases were improved. In the clinical use process, the effective cure rate of the traditional Chinese medicine composition for promoting blood circulation and relieving swelling reaches 100%, and the significant effect cases in all effective cases basically account for the number of main bodies.
In addition, the inventor also clinically uses the products obtained in comparative examples 1-3 to treat 56 patients who are diagnosed, and the preparation and the use methods of the externally applied ointment are the same.
According to statistics, the application cases of the product in the comparative example 1 are 20 cases, the cases of affected parts are 5 cases of crus ankles, and 0 case, 2 cases and 2 cases of effective cases are improved, and 1 case of no effect is obtained in the example; the cases of affected parts at the palmar and wrist parts are 8 cases, and the cases show 2 cases, 4 cases and 2 cases are improved; 4 cases of affected parts at the chest, rib and waist are shown as 0 cases, 1 case with effective cases, 1 case with improved cases and 2 cases without effect; the cases with head affected are 3 cases, and in this case, 1 case is significant, 0 case is significant, 2 cases are better, and 1 case is not significant.
According to statistics, the application cases of the product in the comparative example 2 are 18 cases, the cases of affected parts of crus ankles are 4 cases, and 1 case, 0 case and 3 cases of effective cases are improved in the case; the cases with knee at the affected part were 5 cases, in which 0 cases were significant, 3 cases were better, and 2 cases were not significant; the cases of the affected part at the shoulder and elbow are 5 cases, wherein 1 case is effective, 2 cases are effective and 2 cases are improved; the affected part is the chest rib waist part of 4 cases, in which 0 cases of significant effect example, 3 cases of significant effect example, and the column of improved example 1.
According to statistics, the application cases of the product in the comparative example 3 are 18 cases, the cases of affected parts are 6 cases, and 1 case, 3 cases and 2 cases of effective cases are shown in the example; 8 cases of knee affected parts, 2 cases of significant effect, 3 cases of significant effect and 3 cases of improvement; the cases of affected parts at the shoulders and elbows are 2 cases, in which 0 cases are effective cases, 1 case is effective cases and 1 case is improved; the affected part is the chest rib waist part in 2 cases, and the cases have significant effect example 1, effective example 1 and improved example 0.
In conclusion, the cure effective rate of the products obtained in comparative examples 1-3 is lower than that of the product obtained in example 1, and in effective cases, the effective cases and the good cases account for larger proportions and the treatment effect is weaker.
Finally, it should be noted that the above embodiments are only used for illustrating the technical solutions of the present invention and not for limiting the protection scope of the present invention, and although the present invention is described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications or equivalent substitutions can be made on the technical solutions of the present invention without departing from the spirit and scope of the technical solutions of the present invention.

Claims (8)

1. The traditional Chinese medicine composition for promoting blood circulation and diminishing swelling is characterized by comprising the following components in parts by weight: 40-60 parts of cape jasmine, 10-30 parts of rhizoma cyperi, 20-40 parts of raw rhubarb, 10-30 parts of artemisia anomala, 5-20 parts of madder root, 30-50 parts of radix euphorbiae ceolatae, 4-15 parts of salvia miltiorrhiza, 2-20 parts of radix angelicae pubescentis, 10-30 parts of radix rehmanniae and 2-15 parts of ligusticum chuanxiong hort.
2. The traditional Chinese medicine composition of claim 1, which comprises the following components in parts by weight: 50-60 parts of cape jasmine, 12-25 parts of rhizoma cyperi, 25-40 parts of raw rhubarb, 10-25 parts of artemisia anomala, 8-18 parts of madder root, 35-50 parts of radix euphorbiae ceolatae, 4-15 parts of salvia miltiorrhiza, 2-14 parts of radix angelicae pubescentis, 12-25 parts of radix rehmanniae and 2-10 parts of ligusticum chuanxiong hort.
3. The method for preparing a traditional Chinese medicine composition for promoting blood circulation and removing swelling according to claim 1 or 2, which comprises the following steps: the traditional Chinese medicine composition for promoting blood circulation and relieving swelling is prepared by mixing the components of the traditional Chinese medicine composition for promoting blood circulation and relieving swelling in proportion, drying, crushing and sieving.
4. The method for preparing a Chinese medicinal composition for promoting blood circulation and removing swelling according to claim 1, wherein the mesh number of the sieve is 80-120 meshes.
5. A blood-activating and swelling-diminishing medicine comprising the traditional Chinese medicine composition of claim 1 or 2.
6. The blood circulation-promoting and swelling-dispersing drug according to claim 5, wherein the dosage form of the blood circulation-promoting and swelling-dispersing drug includes an ointment, a patch and a paste.
7. The blood-activating and swelling-dispersing medicine according to claim 6, wherein the blood-activating and swelling-dispersing medicine is a blood-activating and swelling-dispersing externally-applied ointment.
8. The blood-activating and swelling-subsiding medicament as claimed in claim 7, wherein said external ointment for promoting blood circulation and subsiding swelling further comprises at least one of water and honey.
CN202110138997.7A 2021-02-01 2021-02-01 Traditional Chinese medicine composition for promoting blood circulation and diminishing swelling Pending CN112807366A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110138997.7A CN112807366A (en) 2021-02-01 2021-02-01 Traditional Chinese medicine composition for promoting blood circulation and diminishing swelling

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110138997.7A CN112807366A (en) 2021-02-01 2021-02-01 Traditional Chinese medicine composition for promoting blood circulation and diminishing swelling

Publications (1)

Publication Number Publication Date
CN112807366A true CN112807366A (en) 2021-05-18

Family

ID=75861302

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110138997.7A Pending CN112807366A (en) 2021-02-01 2021-02-01 Traditional Chinese medicine composition for promoting blood circulation and diminishing swelling

Country Status (1)

Country Link
CN (1) CN112807366A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1164398A (en) * 1996-05-03 1997-11-12 陈列 Easy-to-use reparcussive pain-stopping plaster
CN101933991A (en) * 2009-07-03 2011-01-05 吉林一正药业集团有限公司 Analgesic and anti-inflammatory medicament and preparation method thereof
CN105687597A (en) * 2016-03-10 2016-06-22 济南正骐生物科技有限公司 Traditional Chinese medicine composition with function of activating blood to remove stasis
CN108743767A (en) * 2018-07-12 2018-11-06 李朝阳 A kind of externally applied drug promoting blood circulation and removing blood stasis and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1164398A (en) * 1996-05-03 1997-11-12 陈列 Easy-to-use reparcussive pain-stopping plaster
CN101933991A (en) * 2009-07-03 2011-01-05 吉林一正药业集团有限公司 Analgesic and anti-inflammatory medicament and preparation method thereof
CN105687597A (en) * 2016-03-10 2016-06-22 济南正骐生物科技有限公司 Traditional Chinese medicine composition with function of activating blood to remove stasis
CN108743767A (en) * 2018-07-12 2018-11-06 李朝阳 A kind of externally applied drug promoting blood circulation and removing blood stasis and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103989864A (en) Externally-applied pain-relieving swelling-removing ointment for traumatic injuries and preparation method thereof
CN101983710B (en) Medicine for external application in orthopedics, production method and application method thereof
CN104998113A (en) Traditional Chinese medicine compound treating dandruff and preparation method thereof
CN103566278B (en) Cortex torricelliae tiliifoliae
CN111494596A (en) External medicine for diminishing inflammation and relieving pain and preparation method thereof
CN112807366A (en) Traditional Chinese medicine composition for promoting blood circulation and diminishing swelling
CN110538272A (en) swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof
CN1106279A (en) Painless bonesetting medicine
CN108785421B (en) A Chinese medicinal composition for treating fracture and its preparation method
CN104524080A (en) Traditional Chinese medicine preparation for treating injuries from falls, fractures, contusions and strains and preparation method
CN100364603C (en) Externally used Chinese herbal medicinal composition
CN103585257A (en) Traditional Chinese medicine powder for treating fractures
CN103417788A (en) Orally taken traditional Chinese medicine for treating fracture
CN100536907C (en) Osteopathy treating Chinese medicine
CN108888736B (en) External-use bone reunion medicine and preparation method thereof
CN1180808C (en) Chinese medicine for treating rheumatic and rheumatoid diseases
CN108066738B (en) Ointment for treating gouty arthritis and preparation method thereof
CN1054067C (en) Medicine for treatment of skin injury and preparation method thereof
CN105617214A (en) Traditional Chinese medicine composition for treating scabies
CN105748887A (en) Traditional Chinese medicine composition for treating insomnia and preparation method of traditional Chinese medicine composition
CN104258239A (en) Orthopedic postoperative blood-activating recovery drug and preparation method thereof
CN105267411B (en) A kind of pharmaceutical composition for treating fracture
CN114028473A (en) A Chinese medicated liquor for treating traumatic injury, and its preparation method
CN115227796A (en) External traditional Chinese medicine formula for treating scapulohumeral periarthritis
CN102824582B (en) Method of preparing traditional Chinese medicine lotion for treating dystrophic type closed fracture

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210518